The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
18F-4V for PET–CT Imaging of VCAM-1 Expression in Atherosclerosis
Open accessAbstract
Objectives To iteratively develope and validate an 18F labeled small molecule VCAM-1 affinity ligand and demonstrate the feasibility of imaging VCAM-1 expression by PET-CT in murine arteries. Background Hybrid PET-CT imaging may allow simultaneous assessment of atherosclerotic lesion morphology (CT) and biology through the development of novel tracers (PET), thus facilitating early risk assessment in individual patients. Methods A cyclic, a linear, and an oligomer affinity peptide, internalized into endothelial cells by VCAM-1–mediated binding, were initially derivatized with DOTA to determine their binding profiles and pharmacokinetics. The lead compound was then 18F labeled and tested in apoE−/− mice as well as models of MI and heart transplant rejection. Results The tetrameric peptide had the highest affinity and specificity for VCAM-1 (97% inhibition with soluble VCAM-1). In vivo PET-CT imaging using 18F-4V showed 0.31±0.02 SUV in murine atheroma (ex vivo %IDGT 5.9±1.5). 18F-4V uptake colocalized with atherosclerotic plaques on Oil Red O staining, and correlated to mRNA levels of VCAM-1 measured by quantitative RT-PCR (R=0.79, p=0.03). Mice treated with atorvastatin had significantly lower lesional uptake (p<0.05). Furthermore, 18F-4V imaging in myocardial ischemia and in transplanted hearts showed good correlation with ex vivo measurement of VCAM-1 mRNA. Conclusion 18F-4V allows noninvasive PET-CT imaging of VCAM-1 in inflammatory atherosclerosis, has the dynamic range to quantify treatment effects and correlates with inflammatory gene expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Self-citationNahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J.-L., Libby, P., Weissleder, R., & Pittet, M. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070885 · Cited by 2,300
Self-citationNahrendorf, M., Jaffer, F. A., Kelly, K. A., Sosnovik, D. E., Aikawa, E., Libby, P., & Weissleder, R. (2006) · Circulation · doi:10.1161/circulationaha.106.646380 · Cited by 602
Self-citationImaging of atherosclerotic cardiovascular disease
Sanz, J., & Fayad, Z. A. (2008) · Nature · doi:10.1038/nature06803 · Cited by 558
Cited by
Monocytes: Protagonists of Infarct Inflammation and Repair After Myocardial Infarction
Nahrendorf, M., Pittet, M. J., & Swirski, F. K. (2010) · Circulation · doi:10.1161/circulationaha.109.916346 · Cited by 799
Self-citationCook-Mills, J. M., Marchese, M. E., & Abdala-Valencia, H. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3522 · Cited by 594
Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects
Kunjachan, S., Ehling, J., Storm, G., Kiessling, F., & Lammers, T. (2015) · Chemical Reviews · doi:10.1021/cr500314d · Cited by 480
Challenges in design and characterization of ligand-targeted drug delivery systems
Muro, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.052 · Cited by 307
Leuschner, F., & Nahrendorf, M. (2011) · Circulation Research · doi:10.1161/circresaha.110.232678 · Cited by 110
Self-citation
Metadata
- Authors
- Nahrendorf, M., Keliher, E., Panizzi, P., Zhang, H., Hembrador, S., Figueiredo, J.-L., Aikawa, E., Kelly, K., Libby, P., & Weissleder, R.
- Venue
- JACC: Cardiovascular Imaging
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 2
- Issue
- 10
- Pages
- 1213-1222
- ISSN
- 1876-7591 (ISSN-L)
- 1936-878X
- OpenAlex
- W41685348
- Cited by
- 224
- References
- 4
- FWCI
- 15.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 18F-4V for PET–CT Imaging of VCAM-1 Expression in Atherosclerosis. https://app.cochat.ai/papers/10.1016/j.jcmg.2009.04.016
- The paper
- Nahrendorf, M., Keliher, E., Panizzi, P., Zhang, H., Hembrador, S., Figueiredo, J.-L., Aikawa, E., Kelly, K., Libby, P., & Weissleder, R. (2009). 18F-4V for PET–CT Imaging of VCAM-1 Expression in Atherosclerosis. JACC: Cardiovascular Imaging. https://doi.org/10.1016/j.jcmg.2009.04.016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.